大肠癌术前血清CEA、CRP联合检测的临床价值  

The clinical value of detecting both CEA and CRP in the serum during preoperation of colorectal carcinoma

作　　者：谭亚黔[1] 常正[1] 张兴明[1] 朱代华[1] 程昀[1] 

机构地区：[1]重庆医科大学第二临床学院外科,400010

出　　处：《重庆医科大学学报》2000年第3期285-286,289,共3页Journal of Chongqing Medical University

摘　　要：目的 探讨大肠癌术前血清ＣＥＡ、ＣＲＰ联合检测的临床价值。方法 对２９７例大肠癌患者测定其ＣＥＡ、ＣＲＰ，从病理分期、癌肿部位和手术方式方面进行研讨。结果 联合检测的总阳性率为９０．５７％，明显高于单项检测者；两项阳性者与手术方式有密切关系；右半结肠癌与左半结肠癌、直肠癌的ＣＲＰ阳性率和均值相比，差异明显。结论 术前血清ＣＥＡ、ＣＲＰ联合检测具有显著的互补性和临床实用价值。Objective TO study the clinical value of detecting both CEA and CRP in the serum of colorectal carcinoma patients before operaion. Methods CEA and CRP of 297 colorectal carcinoma patients were detected and investigated from pathological stage, tumor site and operation type. Results The total positive rate of detecting both CEA and CRP in the serum was 90.57%, obviously higher than that detecting CEA or CRP seperately. That both CEA and CRP were positive was closely related to the operation type. The positive rate of CRP and the average value of ascending colon cancer were remarkably different with that of descending colonal cancer and rectal cancer. Conclusion It has remarkable practical value of detecting CEA and CRP in colorectal carcinoma patients and they can be supplemented with each other.

关 键 词：大肠癌 CEA CRP 联合检测 血清诊断 

分 类 号：R735.340.4[医药卫生—肿瘤] R730.43[医药卫生—临床医学]